{
    "organizations": [],
    "uuid": "869bda4f837e82b886b4de1f9b42513f7446c2f5",
    "author": "",
    "url": "https://www.reuters.com/article/brief-immunogen-inc-reports-qtrly-net-lo/brief-immunogen-inc-reports-qtrly-net-loss-per-common-share-basic-and-diluted-of-0-11-idUSASB0C50G",
    "ord_in_thread": 0,
    "title": "BRIEF-Immunogen Inc Reports Qtrly Net Loss Per Common Share, Basic And Diluted Of $0.11‍​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 41 AM / in 5 minutes BRIEF-Immunogen Inc Reports Qtrly Net Loss Per Common Share, Basic And Diluted Of $0.11‍​   Immunogen Inc: \n* IMMUNOGEN REPORTS PIPELINE PROGRESS AND 2017 OPERATING RESULTS \n* QTRLY NET LOSS PER COMMON SHARE, BASIC AND DILUTED $0.11‍​ * SEES FY 2018 REVENUE $60 MILLION TO $65 MILLION \n* QTRLY TOTAL REVENUES $39.45 MILLION VERSUS $13.85 MILLION \n* IMMUNOGEN - EXPECTS CURRENT CASH COMBINED WITH EXPECTED CASH REVS FROM PARTNERS & COLLABORATORS WILL ENABLE CO TO FUND ITS OPERATIONS INTO Q4 OF 2019 \n* Q4 EARNINGS PER SHARE VIEW $-0.12, REVENUE VIEW $32.7 MILLION -- THOMSON REUTERS I/B/E/S \n* SEES CASH AND CASH EQUIVALENTS AT DECEMBER 31, 2018 BETWEEN $115 MILLION AND $120 MILLION \n* FY2018 REVENUE VIEW $58.7 MILLION -- THOMSON REUTERS I/B/E/S \n* IMMUNOGEN SAYS TO MOVE TO OPERATING MODEL THAT WILL RELY ON EXTERNAL MANUFACTURING AND QUALITY TESTING FOR DRUG SUBSTANCE \n* IMMUNOGEN - TO MOVE TO OPERATING MODEL THAT WILL ALSO RELY ON EXTERNAL MANUFACTURING AND QUALITY TESTING FOR DRUG PRODUCT FOR DEVELOPMENT PROGRAMS \n* DECOMMISSIONING NORWOOD FACILITY WILL RESULT IN ANTICIPATED COST SAVINGS OF OVER $20 MILLION DURING NEXT FIVE YEARS \n* IMMUNOGEN -IMPLEMENTING ‍NEW OPERATING MODEL TO LEAD TO RAMP-DOWN OF MANUFACTURING, QUALITY ACTIVITIES AT NORWOOD, MASSACHUSETTS FACILITY BY 2018 END​ \n* ‍ IMPLEMENTATION OF NEW OPERATING MODEL WILL LEAD TO FULL EXIT AT NORWOOD, MASSACHUSETTS FACILITY BY EARLY 2019​ \n* Q4 EARNINGS PER SHARE VIEW $-0.12 -- THOMSON REUTERS I/B/E/S  ",
    "published": "2018-02-09T13:40:00.000+02:00",
    "crawled": "2018-02-09T13:51:52.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "minute",
        "inc",
        "report",
        "qtrly",
        "net",
        "loss",
        "per",
        "common",
        "share",
        "basic",
        "diluted",
        "immunogen",
        "inc",
        "immunogen",
        "report",
        "pipeline",
        "progress",
        "operating",
        "result",
        "qtrly",
        "net",
        "loss",
        "per",
        "common",
        "share",
        "basic",
        "diluted",
        "see",
        "fy",
        "revenue",
        "million",
        "million",
        "qtrly",
        "total",
        "revenue",
        "million",
        "versus",
        "million",
        "immunogen",
        "expects",
        "current",
        "cash",
        "combined",
        "expected",
        "cash",
        "rev",
        "partner",
        "collaborator",
        "enable",
        "co",
        "fund",
        "operation",
        "q4",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "see",
        "cash",
        "cash",
        "equivalent",
        "december",
        "million",
        "million",
        "fy2018",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "immunogen",
        "say",
        "move",
        "operating",
        "model",
        "rely",
        "external",
        "manufacturing",
        "quality",
        "testing",
        "drug",
        "substance",
        "immunogen",
        "move",
        "operating",
        "model",
        "also",
        "rely",
        "external",
        "manufacturing",
        "quality",
        "testing",
        "drug",
        "product",
        "development",
        "program",
        "decommissioning",
        "norwood",
        "facility",
        "result",
        "anticipated",
        "cost",
        "saving",
        "million",
        "next",
        "five",
        "year",
        "immunogen",
        "operating",
        "model",
        "lead",
        "manufacturing",
        "quality",
        "activity",
        "norwood",
        "massachusetts",
        "facility",
        "implementation",
        "new",
        "operating",
        "model",
        "lead",
        "full",
        "exit",
        "norwood",
        "massachusetts",
        "facility",
        "early",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters"
    ]
}